Rising Geriatric Population Fuels Growth Of Myopia And Presbyopia Treatment Market Emerges as a Core Driver of the Myopia and Presbyopia Treatment Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Myopia and Presbyopia Treatment Market Through 2025?
The market dealing with myopia and presbyopia therapies has experienced robust expansion recently, projected to escalate from a value of $21.04 billion in 2024 to $22.63 billion just one year later in 2025, reflecting a steady compound annual growth rate of 7.6%; this upward trajectory throughout the historical timeframe is fueled by several factors, including the rising incidence of both myopia and presbyopia, greater public education and awareness campaigns, alterations in daily habits centered around increased screen usage, a growing consumer inclination toward alternatives to surgery, expansions in economic conditions and expenditure on health services, ongoing clinical investigations and product innovation, alongside better availability of eye care options.

What's the Projected Size of the Global Myopia and Presbyopia Treatment Market by 2029?
Projections indicate that the market addressing myopia and presbyopia treatments is set for substantial expansion in the upcoming years, reaching a valuation of $31.17 billion by 2029, fueled by a compound annual growth rate of 8.3%. This upward trajectory during the forecasted interval is underpinned by several factors, notably the advent of novel gene therapies aimed at ocular ailments, an increasing emphasis on vision correction as a means of lifestyle improvement, the broadening acceptance of orthokeratology procedures, observable cultural influences shaping eye care habits, and a discernible movement toward proactive eye health management. Key developments anticipated across this period encompass the increasing utilization of telemedicine platforms for vision services, the deployment of pharmacological treatments, the introduction of bespoke contact lenses, the proliferation of devices designed specifically for myopia management, the integration of sophisticated intraocular lenses (IOLs), the performance of refractive surgical procedures to correct presbyopia, and the ongoing evolution of lens implant technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

Top Growth Drivers in the Myopia and Presbyopia Treatment Industry: What's Accelerating the Market?
Prospectively, the expanding elderly demographic is anticipated to be a major catalyst for the progression of the market concerned with treating myopia and presbyopia.This demographic, encompassing individuals aged 65 and above, is susceptible to numerous health issues stemming from diminished immunity associated with advancing years.The process of aging inherently elevates the susceptibility of this older cohort to conditions like myopia, presbyopia, and other ocular ailments.Procedures for managing myopia and presbyopia involve the assessment of both the visual acuity and the microscopic structure of the eyes, with the findings informing the diagnosis and handling of diverse eye conditions within the senior segment.To illustrate this trend, data released by the World Health Organization (WHO), the global public health body headquartered in Switzerland, indicated back in October 2022 that around the year 2030, one-sixth of the global population is projected to have reached the age of 60 or more.Furthermore, projections suggest that by 2050, the worldwide count of individuals aged 60 and over will reach 2.1 billion, with the segment of people aged 80 and above set to surge by 426 million between 2020 and 2050 relative to contemporary figures; consequently, this increasing number of seniors is directly fueling the demand within the myopia and presbyopia treatment industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7892&type=smp

What Trends Will Shape the Myopia and Presbyopia Treatment Market Through 2029 and Beyond?
A significant trend currently shaping the landscape of myopia and presbyopia therapies involves the ascendancy of technologically sophisticated methodologies, with leading market participants prioritizing the innovation of such advanced tools to cement their competitive standing in this domain. Highlighting this drive, in September 2024, Entod Pharmaceuticals, an entity situated in India specializing in manufacturing, introduced PresVu Eye Drops; remarkably, this marked the inaugural ophthalmic drop in India tailor-made for addressing presbyopia, the prevalent vision impairment associated with aging that commonly impacts persons past the age of forty. Having secured approval from the Drug Controller General of India (DCGI), PresVu is engineered not only to offer ocular hydration but crucially, to lessen the reliance on traditional reading spectacles, achieving this efficacy through the incorporation of cutting-edge dynamic buffer technology that guarantees both sustained performance and user safety across prolonged application periods.

What Are the Main Segments in the Myopia and Presbyopia Treatment Market?
The myopia and presbyopia treatmentmarket covered in this report is segmented -

1) By Disease Type: Myopia; Presbyopia
2) By Myopia Treatment Type: Corrective; Surgical; Drugs
3) By Presbyopia Treatment Type: Prescription Lenses; Contact Lenses; Intraocular Lenses; Refractive Surgery

Subsegments:
1) By Myopia: Eyeglasses And Contact Lenses; Refractive Surgery; Pharmacological Treatments; Orthokeratology
2) By Presbyopia: Multifocal Eyeglasses; Bifocal Contact Lenses; Presbyopia-Correcting Surgery; Pharmacological Treatments

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7892&type=smp

Which Top Companies are Driving Growth in the Myopia and Presbyopia Treatment Market?
Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Hagg Striet UK Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Sydnexis Inc., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Novartis AG, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, Ophthotech Corporation, OphthaliX Inc., LensGen Inc., Lightico Ltd., RxSight Inc., Perfect Lens LLC

Which Regions Will Dominate the Myopia and Presbyopia Treatment Market Through 2029?
North America was the largest region in the myopia and presbyopia treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7892

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.